256 Newsroom — Uganda's Digital News Infrastructure
Business

Silence Therapeutics aims at Takeda with new data in rare blood cancer - statnews.com

Published by STAT By Jason Mast · 10 August 2026 at 14:33
Share
Silence Therapeutics aims at Takeda with new data in rare blood cancer - statnews.com
Image · STAT

What the report says

A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.

Read the full report at STAT →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Kampala, Neighbouring Mayors Join Forces to Turn Waste Into EnergyNile Post OPINION: Social media and brokenness pushing HIV numbers through the roofSqoop Uganda Kataleya & Kandle reveal truth behind ‘gifted’ BMWSqoop Uganda 256 Newsroom JACKIE TAHAKANIZIBWA: ESG works best when it becomes everyone’s business - PML DailyPML Daily Four years of SafeCar: How SafeBoda listened to Ugandans and changed car hailingThe Independent Uganda 256 Newsroom Gov’t plans to offer health insurance to elderly people - Daily MonitorDaily Monitor